Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037660 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Lipemia and Metformin on Endothelial Function
A Early Phase 1 study, sponsored by Boston University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 139
- Enrollment target
NCT01037660 is a Early Phase 1 study that has completed, run by Boston University. The registered enrollment target is 139 participants.
The verdict
NCT01037660, a Early Phase 1 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 139 participants
- Enrollment target
Study Summary
Eating a diet high in fat contributes to the development of atherosclerosis (hardening of the arteries). Acute fat consumption increases levels of fat in the blood and temporarily reduces the ability of blood vessel to dilate (open up to carry additional blood). A similar response is observed during infusion of Intra-Lipid (a fat emulsion used for intravenous nutrition). The present study is designed to help us understand the effects of a fat load on blood vessel function. We will measure arterial dilation using non-invasive techniques before and at the end of a 5-hour infusion of Intra-Lipid in healthy subjects. Subjects will then take the approved drug metformin for two weeks and return for repeat studies of endothelial function with Intra-Lipid infusion. We expect that metformin will help preserve the normal function of blood vessels during a fat load. This study will help us understand how fat affects blood vessels and therefore will advance our knowledge of the development of atherosclerosis and potentially lead to improved methods to prevent and treat heart disease.
Interventions
- DRUG Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2005-09 |
| Est. Completion | 2016-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01037660
The ClinicalTrials.gov registry entry for NCT01037660 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin is the first listed.
NCT01037660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01037660 about?
NCT01037660 is a clinical study titled "Effects of Lipemia and Metformin on Endothelial Function". Eating a diet high in fat contributes to the development of atherosclerosis (hardening of the arteries). Acute fat consumption increases levels of fat in the blood and temporarily reduces the ability of blood vessel to dilate (open up to carry additional blood). A similar response is observed during...
What is the current status of trial NCT01037660?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 139 participants. The study started on 2005-09. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT01037660?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT01037660?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.